Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

Journal of Neurochemistry

Volumn 93, Issue 4, 2005, Pages 953-962

  Wang, J ^a   Xiong, S ^b   Xie, C ^b   Markesbery, W R ^b   Lovell, M A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

8 hydroxyguanine; Alzheimer's disease; Gas chromatography mass spectrometry; Mitochondrial DNA; Nuclear DNA; Oxidative stress

Indexed keywords

8 HYDROXYGUANINE; BIOLOGICAL MARKER; CELL NUCLEUS DNA; DNA BASE; MITOCHONDRIAL DNA;

AGING; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA DAMAGE; DNA EXTRACTION; FEMALE; FRONTAL LOBE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ION MONITORING; MALE; MASS SPECTROMETRY; NERVE DEGENERATION; OXIDATIVE STRESS; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; BRAIN; CASE-CONTROL STUDIES; CELL NUCLEUS; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDATION-REDUCTION; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 18844462415     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03053.x     Document Type: Article

References (71)

1. Addya K., Wang Y. L. and Leonard D. G. (1997) Optimization of Apolipoprotein E Genotyping. Mol. Diagn. 2, 271-276.
2. Ames B. N., Shigenaga M. K. and Hagen T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90, 7915-7922.
3. Anon (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging 18, S1-S2.
4. Aruoma O. I., Halliwell B., Gajewski E. and Dizdaroglu M. (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J. Biol. Chem. 264, 20 509-20 512.
5. Birincioglu M., Jaruga P., Chowdhury G., Rodriguez H., Dizdaroglu M. and Gates K. S. (2003) DNA base damage by the antitumor agent 3-amino-1,2,4- benzotriazine 1,4-dioxide (tirapazamine). J. Am. Chem. Soc. 125, 11 607-11 615.
6. Braak H. and Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239-259.
7. Bruce-Keller A. J., Li Y. J., Lovell M. A., Kraemer P. J., Gary D. S., Brown R. R., Markesbery W. R. and Mattson M. P. (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. 57, 257-267.
8. Butterfield D. A. (2003) Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr. Med. Chem. 10, 2651-2659.
9. Butterfield D. A., Yatin S. M., Varadarajan S. and Koppal T. (1999) Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease. Meth. Enzymol. 309, 746-768.
10. Butterfield D. A., Boyd-Kimball D. and Castegna A. (2003) Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J. Neurochem. 86, 1313-1327.
11. Cheng K. C., Cahill D. S., Kasai H., Nishimura S. and Loeb L. A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-Tand A-C substitutions. J. Biol. Chem. 267, 166-172.
12. Cooke M. S., Evans M. D., Dizdaroglu M. and Lunec J. (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 1195-1214.
13. Cornell C. R., Markesbery W. R. and Ehmann W. D. (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
14. Crawford D. R., Suzuki T., Sesay J. and Davies K. J. (2002) Analysis of gene expression following oxidative stress. Meth. Mol. Biol. 196, 155-162.
15. Davies K. J. (1995) Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61, 1-31.
16. Dizdaroglu M. (1998) Facts about the artifacts in the measurement of oxidative DNA base damage by gas chromatography-mass spectrometry. Free Radic. Res. 29, 551-563.
17. Dizdaroglu M., Jaruga P., Birincioglu M. and Rodriguez H. (2002) Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 32, 1102-1115.
18. Douki T., Delateur T., Bianchini F. and Cadet J. (1996) Observation and prevention of an artefactual formation of oxidized DNA bases and nucleosides in the GC-EIMS method. Carcinogenesis 17, 347-353.
19. Dyrks T., Dyrks E., Hartmann T., Masters C. and Beyreuther K. (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18 210-18 217.
20. Dyrks T., Dyrks E., Masters C. L. and Beyreuther K. (1993) Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett. 324, 231-236.
21. Eckert A., Keil U., Marques C. A., Bonert A., Frey C., Schussel K. and Muller W. E. (2003) Mitochondrial dysfiinction, apoptotic cell death, and Alzheimer's disease. Biochem. Pharmacol. 66, 1627-1634.
22. Floyd R. A. (1999) Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26, 1346-1355.
23. Floyd R. A., West M. S., Eneff K. L., Schneider J. E., Wong P. K., Tingey D. T. and Hogsett W. E. (1990) Conditions influencing yield and analysis of 8-hydroxy-2′-deoxyguanosine in oxidatively damaged DNA. Anal. Biochem. 188, 155-158.
24. Gabbita S. P., Lovell M. A. and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 2034-2040.
25. Gearing M., Mirra S. S., Hedreen J. C., Sumi S. M., Hansen L. A. and Heyman A. (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45, 461-466.
26. Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 75-87.
27. Halliwell B. and Gutterridge J. (1989) Free Radicals in Biology and Medicine, 2nd Ed. Oxford University Press, New York.
28. Harman D. (1973) Free radical theory of aging. Triangle 12, 153-158.
29. Harman D. (2003) The free radical theory of aging. Antioxid. Redox Signal. 5, 557-561.
30. Hensley K., Hall N., Subramaniam R. et al. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
31. Herbert K. E., Evans M. D., Finnegan M. T., Farooq S., Mistry N., Podmore I. D., Farmer P. and Lunec J. (1996) A novel HPLC procedure for the analysis of 8-oxoguanine in DNA. Free Radic. Biol. Med. 20, 461-412.
32. Lovell M. A., Ehmann W. D., Butler S. M. and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
33. Lovell M. A., Ehmann W. D., Mattson M. P. and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
34. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
35. Lovell M. A., Gabbita S. P. and Markesbery W. R. (1999) Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72, 771-776.
36. Lovell M. A., Xie C. and Markesbery W. R. (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic. Biol. Med. 29, 714-720.
37. Lovell M. A., Xie C. and Markesbery W. R. (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187-194.
38. Lovell M. A., Robertson J. D., Buchholz B. A., Xie C. and Markesbery W. R. (2002) Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging 23, 179-186.
39. Lustbader J. W., Cirilli M., Lin C. et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304, 448-452.
40. Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
41. Marcus D. L., Thomas C., Rodriguez C., Simberkoff K., Tsai J. S., Strafaci J. A. and Freedman M. L. (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150, 40-44.
42. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
43. Markesbery W. R. and Carney J. M. (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol. 9, 133-146.
44. Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
45. Markesbery W. R., Montine T. J. and Lovell M. A. (2001) Oxidative alterations in neurodegenerative diseases. Pathogenesis of Neurodegenerative Disorders (Mattson, M., ed.). Humana Press, Totowa, NJ.
46. Marietta M. A. (1993) Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268, 12 231-12 234.
47. Martin J. B. (1999) Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340, 1970-1980.
48. McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984) Clinical Diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
49. Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C. and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609-616.
50. Mecocci P., MacGarvey U. and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
51. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G. and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
52. Montine T. J., Markesbery W. R., Morrow J. D., Roberts L. J. 2nd (1998) Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44, 410-413.
53. Montine T. J., Kaye J. A., Montine K. S., McFarland L., Morrow J. D. and Quinn J. F. (2001) Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Arch. Pathol. Lab. Med. 125, 510-512.
54. Montine T. J., Neely M. D., Quinn J. F., Beal M. F., Markesbery W. R., Roberts L. J. and Morrow J. D. (2002) Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33, 620-626.
55. Musiek E. S., Cha J. K., Yin H., Zackert W. E., Terry E. S., Porter N. A., Montine T. J. and Morrow J. D. (2004) Quantification of F-ring isoprostane-like compounds (F(4)-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 799, 95-102.
56. Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S. and Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19, 1959-1964.
57. Orth M. and Schapira A. H. (2001) Mitochondria and degenerative disorders. Am. J. Med. Genet. 106, 27-36.
58. Pratico D. (2002) Alzheimer's disease and oxygen radicals: new insights. Biochem. Pharmacol. 63, 563-567.
59. Richter C., Park J. W. and Ames B. N. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl Acad. Sci. USA 85, 6465-6467.
60. Sampson J. B. Ye Y., Rosen H. and Beckman J. S. (1998) Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch. Biochem. Biophys. 356, 207-213.
61. Schofield P. and Mayeux R. (1998) Alzheimer's Disease: clinical features, diagnosis and epidemiology, in Neuropathology of Dementing Disorders (Markesbery, W. R., ed.), pp. 89-105. Arnold, London.
62. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W. and Wolf P. A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483.
63. Smith M. A., Vasak M., Knipp M., Castellani R. J. and Perry G. (1998) Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease. Free Radic. Biol. Med. 25, 898-902.
64. Smith M. A., Nunomura A., Zhu X., Takeda A. and Perry G. (2000a) Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid. Redox Signal. 1, 413-420.
65. Smith M. A., Rottkamp C. A., Nunomura A., Raina A. K. and Perry G. (2000b) Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502, 139-144.
66. Steenken S. (1989) Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reaction of their radical cations and e and OH adducts. Chem. Rev. 89, 503-520.
67. Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K. and Teramoto T. (1993) Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 121, 598-602.
68. Varadarajan S., Yatin S., Aksenova M. and Butterfield D. A. (2000) Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184-208.
69. Wallace D. C. (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628-632.
70. Wallace D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
71. Xie C. X., Mattson M. P., Lovell M. A. and Yokel R. A. (1996) Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons. Brain Res. 743, 271-277.